(Q33441675)

English

A phase II trial of oral 4'demethoxydaunorubicin (DMDR) in inoperable non small cell lung cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A phase II trial of oral 4'demethoxydaunorubicin (DMDR) in inoperable non small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase II clinical trial

0 references

author name string

Presgrave P

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Woods R

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kefford R

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Bell D

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Raghavan D

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Levi J

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 September 1988

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

219-221

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase I study of 4-demethoxydaunorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2847993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2847993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental evaluation of anthracycline analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/2847993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2847993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/2847993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of 4-demethoxydaunorubicin administered orally

1 reference

https://pubmed.ncbi.nlm.nih.gov/2847993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2847993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00175402

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33441675&oldid=2195366387"